Nephrocare Health Services Limited has informed the Exchange of Designation of Mr. Prashant Vinodkumar Goenka, Chief Financial Officer as the Chief Risk Officer of the company w.e.f. April, 03, 2026 in addition to his existing responsibilities as per SEBI Listing Regulations.
NEPHROPLUS · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Nephrocare Health Services Limited has appointed Mr. Prashant Vinodkumar Goenka, currently the Chief Financial Officer, as the additional Chief Risk Officer (CRO) of the company effective April 3, 2026. This designation comes under SEBI Listing Regulations and adds risk management responsibilities to his existing finance leadership duties. Goenka, who has been with the company since May 2024, holds strong credentials including an MBA from University of Chicago Booth School of Business and over 20 years of experience in financial services with major banks like HSBC, Bank of America, and JP Morgan Chase. He will continue to handle finance, strategy, administration, secretarial, and technology functions alongside the new CRO responsibilities.
This internal appointment consolidates financial oversight and risk management under one executive, which may signal tighter internal controls but has no immediate material impact on shareholder value as it involves an existing KMP taking on additional duties without change in compensation structure.